vimarsana.com

Page 141 - ஜெர்மன் கூட்டாட்சியின் அமைச்சகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

3D-printed engine is 20 percent lighter

IPM s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration

IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration IPM’s New Drug Application for Dapivirine Vaginal Ring to Reduce HIV Risk in Women Accepted for Filing by US Food and Drug Administration SILVER SPRING, Md. (March 3, 2021) The nonprofit International Partnership for Microbicides (IPM) announced today that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for the monthly dapivirine vaginal ring, designed to reduce the risk of HIV-1 infection through vaginal sex.  Made of flexible silicone, the investigational product releases an antiretroviral drug (ARV) called dapivirine over the course of one month. Women can insert and replace the ring themselves. IPM designed the ring to offer women a discreet and long-acting HIV prevention choice that they can control themselves. 

Synthetische Kraftstoffe: FDP fordert Gleichstellung zur Elektromobilität

Synthetische Kraftstoffe: FDP fordert Gleichstellung zur Elektromobilität
focus.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from focus.de Daily Mail and Mail on Sunday newspapers.

Newly founded biotech company ActiTrexx receives funding of € 3 5 million to develop cell therapy ag

DGAP-News: ActiTrexx GmbH / Key word(s): Financing02.03.2021 / 09:00 The issuer is solely responsible for the content of this announcement.Newly founded biotech company ActiTrexx receives funding of € 3.5 million to develop cell therapy against transplant rejectionMainz, Germany, 02. March 2021 - ActiTrexx.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.